Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis b
Symptom |chronic infection
Sentences 209
PubMedID- 20085587 In addition, a possible association between chronic infection with hepatitis b and c viruses and cholangiocarcinoma was also noted.
PubMedID- 22184515 The main hepatic complications of multiple transfusions include acute and chronic infection with hepatitis b and c and iron overload.
PubMedID- 25512154 Findings: chronic infection with epstein-barr virus, hepatitis b and c viruses, kaposi sarcoma herpes virus, human immunodeficiency virus (hiv) type 1, human papillomavirus (hpv), human t-cell lymphotropic virus type 1, helicobacter pylori, clonorchis sinensis, opisthorchis viverrini, and schistosoma haematobium are associated with nasopharyngeal carcinoma; lymphoma and leukemia, including non-hodgkin lymphoma, hodgkin lymphoma, and burkitt lymphoma; hepatocellular carcinoma; kaposi sarcoma; oropharyngeal carcinoma; cervical carcinoma and carcinoma of other anogential sites; adult t-cell leukemia/lymphoma; gastric carcinoma; cholangiocarcinoma; and urinary bladder cancer.
PubMedID- 26434859 chronic infection with the hepatitis b virus is the major factor leading to hcc progression since it causes the liver injury.
PubMedID- 24373091 Hepatocellular carcinoma (hcc) is a frequent, long term complication of chronic infection with hepatitis b virus (hbv) with an annual incidence ranging from 2 to 5%, often independent from the histological stage of underlying liver disease and serological status.
PubMedID- 25884472 Most cases of hcc are attributed to chronic infection with either hepatitis b or c virus 2.
PubMedID- 21682827 Although chronic infection with hepatitis b virus (hbv) and/or hepatitis c virus (hcv) are the most important risk factors for the development of hepatocellular carcinoma (hcc) worldwide, the proportion of hcc patients negative for the hepatitis b surface antigen and hepatitis c antibody, so-called "non-b non-c hcc", is rapidly increasing, especially in japan.
PubMedID- 23718853 chronic infection of hepatitis b and c can advances to cirrhosis and hcc.
PubMedID- 23437062 chronic infection with hepatitis b virus (hbv) and hepatitis c virus (hcv), alcohol abuse, environmental and occupational toxins, as well as certain metabolic and immune disorders are risk factors of hcc .
PubMedID- 23593449 It is well-known to be associated with the chronic infection of hepatitis b (hbv) and hepatitis c (hcv) viruses.
PubMedID- 24336972 chronic infection with hepatitis b virus (hbv) is the major risk factor for the development of hcc, while hepatitis b virus x protein (hbx) is essential for hbv-associated hcc.
PubMedID- 20429960 chronic infection with hepatitis b virus (hbv) occurs in approximately 6% of the world's population and carriers of the virus are at risk for hepatocellular carcinoma and cirrhosis.
PubMedID- 26317595 Background: chronic infection with the hepatitis b virus and obesity may both contribute synergistically to liver disease, although relatively few studies have investigated this hypothesis.
PubMedID- 24936402 In his medical history, the existence of a non-insulin dependent diabetes and asymptomatic chronic infection with hepatitis b virus (hbv) were recorded.
PubMedID- 22190911 Innate and adaptive immune systems have important role in the pathogenesis of acute and chronic infection with hepatitis b virus (hbv).
PubMedID- 24376578 Previous epidemiological studies have identified that major risk factors for the development of hcc are chronic infection with hepatitis b virus (hbv) or hepatitis c virus (hcv), liver cirrhosis, habitual alcohol abuse, and exposure to aflatoxin b1 .
PubMedID- 23039099 Epidemiologic and experimental evidence has shown that chronic infection with hepatitis b and c virus (hbv, hcv) is a major risk factor for hepatocellular carcinoma (hcc).
PubMedID- 24708820 Morocco is a country of intermediate endemicity for chronic infections with hepatitis b (hbv) and c (hcv) viruses, where a consistently low level of food contamination by aflatoxins b1.
PubMedID- 21268724 Background: chronic infection with hepatitis b virus and hepatitis delta virus (hdv) results in the most severe form of viral hepatitis.
PubMedID- 23400006 A major risk factor is chronic infection with hepatitis b virus (hbv) or hepatitis c virus (hcv)8.
PubMedID- 26139985 chronic infection with the hepatitis b virus (hbv) is the leading risk factor for the development of hepatocellular carcinoma (hcc).
PubMedID- 20331884 chronic infections with hepatitis b virus (hbv) and hepatitis c virus (hcv) are a leading cause of hepatocellular carcinoma, a condition whose incidence rate remains high in the developing world and is rising across most developed countries 1.
PubMedID- 23024757 Among them, chronic infection with hepatitis b virus (hbv) is one of the major etiological factors for developing hcc with considerable regional variations ranging from 20% of hcc cases in japan to 65% in china 3.
PubMedID- 22807686 Major risk factors for hcc are chronic infections with the hepatitis b or c viruses, and exposure to dietary aflatoxin b1.
PubMedID- 23323209 The world health organization has estimated that the prevalence of chronic infections with hepatitis b virus (hbv) and hepatitis c virus (hcv) is more than 5% of the world population.
PubMedID- 25750558 chronic infection with the hepatitis b virus (hbv) is a major cause of cirrhosis and hepatocellular carcinoma (hcc) worldwide.
PubMedID- 22230186 chronic infection with hepatitis b virus (hbv) frequently leads to serious liver disease such as cirrhosis, fulminant hepatic failure, and hepatocellular carcinoma 1.
PubMedID- 21261993 chronic infection with hepatitis b virus (hbv) or hepatitis c virus (hcv) is associated with increased morbidity and mortality.
PubMedID- 21618261 Background: chronic infection with hepatitis b virus and hepatitis delta virus (hdv) results in the most severe form of viral hepatitis.
PubMedID- 23433483 chronic infection with hepatitis b or c viruses and alcohol consumption are considered the most important risk factors for liver cancer.
PubMedID- 22923916 chronic infection with hepatitis b virus (hbv) is a global public health problem, often called the ‘silent killer’, which eventually leads to liver cirrhosis, decompensated hepatic disease, or hepatocellular carcinoma in 20-40% of patients.
PubMedID- 22969921 Previous epidemiological studies have found that chronic infection with hepatitis b virus (hbv) is one of the major etiological risk factors for hcc in china.
PubMedID- 20628618 Hepatocellular carcinoma (hcc) is a primary cancer that originates in hepatocytes and typically follows cirrhosis or chronic-hepatitis virus infections , and the most significant risk factors for hcc are chronic infections with either hepatitis b virus or hepatitis c virus (hcv).
PubMedID- 22114736 The highest hcc incidence rates are areas endemic for chronic infection with hepatitis b virus (asia and africa).
PubMedID- 26453548 In eastern asian countries, including taiwan, chronic infection with hepatitis b virus (hbv) is the dominant risk factor .
PubMedID- 22611419 In chronic infection with hepatitis b virus or hcv, specific ctls are few and engage few specific targets; they also display anergic characteristics with reduced type 1 cytokine secretion .
PubMedID- 25034398 Background: chronic infection with hepatitis b virus (hbv) is the major risk factor of hepatocellular carcinoma (hcc).
PubMedID- 23012649 They found that adefovir dipivoxil (9-.
PubMedID- 26102214 The main risk factor for hcc is chronic infection with hepatitis b or c that may lead to cirrhosis which is present in 80% to 90% of the cases of hcc .
PubMedID- 24397793 chronic infection with hepatitis b virus (hbv) is a major cause of death from cirrhosis and liver cancer, chiefly in south-east asia and sub-saharan africa .
PubMedID- 24914367 chronic infections with hepatitis b virus (hbv) and/or hepatitis c virus (hcv) are the major causes of cirrhosis globally.
PubMedID- 24133665 A chronic infection with hepatitis b virus (hbv) results in substantial morbidity and mortality worldwide, claiming up to 1 million deaths annually.1 chronic hepatitis b (chb) can be a silent disease for decades, but cirrhosis, liver failure, and hepatocellular carcinoma (hcc) can be the result of untreated infection.2,3 lamivudine (lam) is the first nucleoside analog approved for treatment of chb, and has been applied globally for chb patients.
PubMedID- 20889864 Chronic viral hepatitis is common among adults in many tropical and sub-tropical countries where dengue is endemic, and it has been postulated that dengue infection occurring on a background of chronic infection with hepatitis b virus (hbv) or hepatitis c virus (hcv) may result in more severe liver dysfunction and/or hemorrhage than is usual in non-infected persons.
PubMedID- 24379608 chronic infection with hepatitis b virus (hbv) and hepatitis c virus accounts for approximately 75%-80% of hcc cases worldwide.
PubMedID- 25338920 chronic infection with hepatitis b virus (hbv) puts individuals at high risk for complicating cirrhosis and liver cancer, but available treatment to counter the virus rarely eliminates infection.
PubMedID- 22448225 Background and aims: chronic infection with the hepatitis b virus (hbv) is a major health issue worldwide.
PubMedID- 21243800 Vaccination of the newborns and adolescents had impact on the incidence of acute and chronic infection with hepatitis b virus (hbv) in children.
PubMedID- 22171899 chronic infection with hepatitis b virus (hbv) is a major risk factor for hcc, accounting for more than one half of cases worldwide (2).
PubMedID- 21573166 Among the well known risk factors for hcc, chronic infection with hepatitis b (hbv) or c (hcv) virus is present in more than 85% of primary liver cancers 1.
PubMedID- 23188673 Overwhelmingly, chronic infection with hepatitis b virus (hbv) is recognized important risk factors of hcc in many countries, including china.

Page: 1 2 3 4 5